key: cord-0921239-f5azpaum
authors: Menon, Deepak; Alnajjar, Sara; Barnett, Carolina; Vijayan, Joy; Katzberg, Hans; Fathi, Davood; Alcantara, Monica; Bril, Vera
title: Telephone consultation for myasthenia gravis care during the COVID‐19 pandemic: Assessment of a novel virtual myasthenia gravis index
date: 2021-04-19
journal: Muscle Nerve
DOI: 10.1002/mus.27243
sha: f68164e4786b0bd8ce890349eb43d36bc98985cf
doc_id: 921239
cord_uid: f5azpaum

INTRODUCTION/AIMS: The aim of the study was to determine the association between the virtual Myasthenia Gravis Impairment Index (vMGII) with other patient‐reported outcomes (PROs) of myasthenia gravis (MG) and its usefulness in telephone consultations with MG patients. METHODS: This was a retrospective case series in which vMGII score along with virtual Single Simple Question (vSSQ), virtual Patient‐Acceptable Symptom State PASS (vPASS) response, and patient disease status based on Myathenia Gravis Foundation of America postintervention status were collected during telephone consultation along with the MGII, SSQ, and PASS responses during the preceding in‐person clinic visits. RESULTS: In 214 patients, the mean difference of vMGII between the vPASS “Yes” and “No” groups was −14.2 ± 1.4 (95% confidence interval, −16.9 to −11.3; P < .001) with mean vMGII for vPASS “Yes” group being 6.4 ± 7.7 and vPASS “No” being 20.5 ± 11.5. A vMGII of 11.5 or higher predicted vPASS “yes” response with a sensitivity of 78.7% and specificity of 81.4%. A strong negative correlation was found between the vMGII and vSSQ (r = −.667; P < .001). The mean vMGII was 0.48 ± 1.42 for patients in remission, and 9.31 ± 10.93 for improved, 9.32 ± 8.79 for stable, and 22.58 ± 14.04 for worsened groups (P < .001). These associations were the same as those obtained during the preceding in‐person clinic visit and the direction of change in MGII scores also indicated change in disease status. DISCUSSION: vMGII is an effective measure to assess an MG patient's disease status in telephone consultations and relates well with other PRO measures. The vMGII remains reliable for assessing MG disease status even with removal of the physical examination component.

Other easy-to-apply patient-reported outcomes (PROs), such as Patient-Acceptable Symptom State (PASS) response and Single Simple Question (SSQ) response, may also be valuable virtual tools in this respect; they have been examined previously and are being utilized in MG assessment. [5] [6] [7] The objective of the current study was to evaluate the association of vMGII with other established patient outcome measures and thus explore its usefulness in identifying MG disease status during telephone consultations.

We retrospectively collected data from consecutive patients who were followed-up through telephone consultation from the Prosserman Family Neuromuscular Clinic of the Toronto General Hospital from April 1, 2020 until August 15, 2020. Only patients older than 18 years of age and who had been seen at least once previously for an in-person clinic visit with a definite diagnosis of MG, defined by appropriate clinical history with single-fiber electromyography showing increased jitter, with or without seropositivity, were included.

During routine, continued, in-person MG clinic visits, we obtain MGII, SSQ, and PASS information, as well as patient history. Physical examination is performed, which includes Medical Research Council scoring of muscle strength and forced vital capacity using a hand-held spirometer. Both PASS and SSQ are PROs and have been validated with the PASS "Yes" response, with higher SSQ percentages signifying better patient status. 6,7 MGII has 22 patient-reported and 6 physician-assessed items with a final composite score of 84, with higher score signifying greater disability. 3 Since the beginning of the restrictions enforced by the COVID pandemic, we were engaged in telephone consultations for follow-up 

SPSS version 20 software (IBM Corp, Armonk, New York) was used for data analysis. Data used to describe the demographic and clinical variables are presented as mean and standard deviation or as number and percent, as appropriate. Comparison of the vMGII with vPASS was done using independent t tests, whereas that with vSSQ was done with Pearson correlations. A receiver operating characteristic (ROC) curve was drawn between vMGII and vPASS to determine the vMGII cut-off that would predict the PASS "yes" response. We expected to find similar thresholds to those of previous studies. Analysis of variance was used to compare the means of vMGII between the MG diseases status based on MGFA PIS during the telephone consultation. As an internal control, an association and correlation was also drawn between the MGII and the corresponding PASS and SSQ during the previous inpatient visit. Last, the difference in scores between the vMGII and the previous MGII obtained during the clinical visit (delta MGII) was obtained, and its association with MG disease status (MGFA PIS) was determined during telephone consultation. P < .05 was considered statistically significant. When possible, missing data were imputed according to the instructions of each outcome measure.

We identified 214 patients with MG who had telephone consultations during the study period and who satisfied the selection criteria. The mean age of the patients was 61.5 ± 15.8 years. The majority (n = 133, 62.1%) were female. Detailed demographic and clinical parameters are summarized in Table 1 . visit, and a direction of change in scores between the in-person and virtual visit also predicted the change in disease status.

The advantage of telephone consultation as a virtual care platform is that it is the most accessible and least technically demanding to arrange, especially from a patient's perspective. 8 However, the lack of means for physical assessment is the major drawback and raises challenges not only for a first-time consultation, but also for patients followed for chronic neurological conditions. 9 Some of these chal- knowledge, have not been tested prospectively in a significant number of patients with MG. 10,11 MGII has the advantage over MG-ADL in having less of a floor effect, and has advantages over the QMGS in that the MGII is simpler, less time-consuming, and is centered around the patient's symptoms. 3, 12 Its strong correlation with other PROs, such as PASS and SSQ, has been also been established. [5] [6] [7] It is uncertain whether the responses obtained via a telephone interview differ from those obtained through a face-to-face interview. 13 For the vMGII, the mode of questionnaire administration may affect the patient response. 14 For in-person consultations, during which the questionnaires are answered without interaction with the health-care provider, the patients have more time to contemplate and reflect or get a bystander's opinion to aid in their responses. 15 It may be that in-person responses have better reliability than telephone-administered surveys in certain research settings. 16 Although previous studies showed that PROs obtained via phone interviews were not inferior to self-survey by patients in the clinic, the method of administering the questionnaire likely impacts patient responses. 14, 17, 18 Although in most cases the vMGII was collected at the beginning of the interview, this procedure was not followed in all telephone consultations performed in our study, and interviewer bias is inherent in this mode of response collection. Both of these are limitations of the study. In a prospective study, a blinded rater may be used, but the current methodology is pragmatic and best suited to examining the utility of the vMGII in the real-world setting. In addition, in this cohort all patients were familiar with the MGII from their routine clinic visits, which probably made phone assessment easier.

Another method that may make telephone assessment more efficient would be to send the online questionnaire to the patient for completion before the telephone interview, and such an approach may be 19, 20 In the current study, higher vMGII scores were observed for patients with comorbidities, most significantly among those with depression. Similar discrepancies have been noted during in-person clinical visits, even with full MGII and routine clinical assessment. As such, this limitation is not unique to the virtual world, and in most situations a relevant history reveals the true cause of the apparent worsening in disease status. Last, our study was a singlecenter investigation and had a relatively low percentage of patients with seropositivity, 21, 22 which cautions against the generalizability of our findings. Further multicenter, cross-cultural studies are required.

In conclusion, in this study we have shown that the vMGII is a valuable and simple way to provide telephone care to MG patients and that it associates well with other PRO measures and disease status. The lack of a physical examination did not prevent the vMGII from providing an MG disease assessment that was comparable to that with a full MGII, and therefore a visual media interface may not be more informative.

Future prospective studies will be needed to establish vMGII as a standard of care in telephone consultations for MG.

The authors declare no potential conflicts of interest.

We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.

The data that support the findings of this study are available from the corresponding author upon reasonable request ORCID Deepak Menon https://orcid.org/0000-0001-7360-417X

Carolina Barnett https://orcid.org/0000-0001-5546-0221

Telemedicine and virtual care guidelines for health professionals. R Coll Phys Surg Canada

Tackling the burden of neurological diseases in Canada with virtual care during the COVID-19 pandemic and beyond

Development and validation of the myasthenia gravis impairment index

Myasthenia gravis impairment index: responsiveness, meaningful change, and relative efficiency

Patientacceptable symptom states in myasthenia gravis

The utility of a single simple question in the evaluation of patients with myasthenia gravis

Comparison of the single simple question and the patient acceptable symptom state in myasthenia gravis

Management of neurological care during the COVID-19 pandemic

Teleneurology applications

Telemedicine for neuromuscular disorders during the COVID-19 outbreak

Teleneurology during the COVID-19 pandemic: a step forward in modernizing medical care

Measuring clinical treatment response in myasthenia gravis

Personal versus telephone interviews: effect on responses

Mode of questionnaire administration can have serious effects on data quality

Comparison of face-to-face and telephone consultations in primary care: qualitative analysis

Comparing the reliability of responses to telephone-administered vs. self-administered webbased surveys in a case-control study of adult malignant brain cancer

An equivalence study: are patient-completed and telephone interview equivalent modes of administration for the EuroQol survey? Health Qual Life Outcomes

Assessing patient-reported outcomes measures via phone interviews versus patient self-survey in clinic: are we measuring the same thing?

Association of psychological status and patient-reported physical outcome measures in joint arthroplasty: a lack of divergent validity

The impact of comorbidity on patient-reported outcomes in psoriatic arthritis: a systematic literature review

Clinical utility of acetylcholine receptor antibody testing in ocular myasthenia gravis

Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays

Telephone consultation for myasthenia gravis care during the COVID-19 pandemic: Assessment of a novel virtual myasthenia gravis index